Molina Healthcare Inc reports results for the quarter ended September 30 - Earnings Summary

By Reuters News
  • Molina Healthcare Inc MOH.N reported quarterly adjusted earnings of 89 cents​​ per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of $1.84. The mean expectation of twenty analysts for the quarter was for earnings of 74 cents per share. Wall Street expected results to range from 69 cents to 85 cents per share.

  • Revenue fell 3.4% to $11.08 billion from a year ago; analysts expected $10.81 billion.

  • Molina Healthcare Inc's reported EPS for the quarter was 73 cents​.

  • The company reported quarterly net income of $38 million.

  • Molina Healthcare Inc shares had risen by 16.2% this quarter and gained 26.6% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts had fallen by about 38% in the last three months.​

  • In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy," 16 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the managed healthcare peer group is "buy."

  • Wall Street's median 12-month price target for Molina Healthcare Inc is $209.00, about 2.8% below its last closing price of $214.90

This summary was machine generated from LSEG data October 21 at 09:37 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Sep. 30 2026

0.74

0.89

Beat

Jun. 30 2026

1.39

1.51

Beat

Mar. 31 2026

1.92

2.35

Beat

Dec. 31 2025

0.33

-2.75

Missed

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.
 

Cryptocurrency-related content is intended solely as news and market commentary. Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd.